Richard Browne
About Richard Browne
Richard Browne serves as the Access & External Affairs Director at Aimmune Therapeutics, where he has worked since 2021. He has extensive experience in market access roles across several pharmaceutical companies, including Novo Nordisk, AbbVie, Sanofi, and Janssen-Cilag.
Current Role at Aimmune Therapeutics
Richard Browne serves as the Access & External Affairs Director at Aimmune Therapeutics. He has held this position since 2021, contributing to the company's strategic initiatives in access and external affairs. His role involves navigating the complexities of market access and ensuring that Aimmune's products reach the patients who need them.
Previous Experience in Market Access
Prior to his current role, Richard Browne accumulated extensive experience in market access across various organizations. He worked at Novo Nordisk as the Interim Market Access Manager for Obesity in 2020. His tenure at AbbVie included roles as Senior Market Access Value Proposition Manager for both the HCV and Dermatology franchises from 2014 to 2016. Additionally, he held positions at Sanofi as Value and Access Manager for Immunology from 2016 to 2019, further enhancing his expertise in the field.
Educational Background in Biochemistry and Physiology
Richard Browne studied at the University of Southampton from 1990 to 1995, focusing on Rheumatology and diabetes. He achieved a comprehensive understanding of Biochemistry, Physiology, and Nutrition during his five years of study. This educational foundation supports his professional roles in market access and external affairs within the healthcare sector.
Longstanding Career in Healthcare
Richard Browne has built a longstanding career in the healthcare industry, with significant experience in market access and value proposition management. His career includes a six-year tenure at Janssen-Cilag as Health Economy Liaison Manager, where he focused on market access strategies. His diverse roles across multiple organizations reflect his commitment to improving patient access to healthcare solutions.